The SFJ Pharmaceuticals Group is a global Pharmaceutical company with an innovative business model that provides a financially advantageous and creative approach to drug development. SFJ’s unique partnering model pairs strategic funding and experienced clinical development resources with late phase drug development candidates across multiple indications. The result is accelerated portfolio expansion with minimal financial risk.
SFJ Pharmaceuticals Group is staffed with a seasoned team of professionals, with extensive experience in the clinical development and regulatory approval of pharmaceutical products on a global basis.
SFJ Pharmaceuticals Group has offices in the United States, Japan, Singapore, Korea, China, Spain and Germany.